Skip to main content
Erschienen in: Cancer Causes & Control 3/2009

01.04.2009 | Original Paper

Body size and breast cancer in a black population—The Barbados National Cancer Study

verfasst von: Barbara Nemesure, Suh-Yuh Wu, Anselm Hennis, M. Cristina Leske, Barbados National Cancer Study Group

Erschienen in: Cancer Causes & Control | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Objective

To evaluate the relationship between body size and incident breast cancer in an African-origin Caribbean population.

Methods

This investigation is based on 222 incident breast cancer cases and 454 controls from the Barbados National Cancer Study (BNCS) in whom body size variables that included height, weight, body-mass index (BMI), waist and hip circumferences (WC, HC), and waist−hip ratio (WHR) were compared. Multivariate-adjusted logistic regression analyses were performed and the findings are presented as odds ratios (ORs) with 95% confidence intervals (CI).

Results

Although 33% of cases and 39% of controls were obese (BMI ≥ 30 kg/m2), BMI was not found to be a significant predictor of breast cancer in the multivariate analyses. Tall stature increased risk among women ≥50 years (OR = 2.16, 95% CI (1.02, 4.58)), and a dual effect with age was suggested for both WC and WHR (decreased risk for those aged ≤50 years; increased risk among those ≥50 years).

Conclusions

Body size appears to influence the risk of breast cancer in this population of African origin. The BNCS data suggest that a few, but not all body size factors play a role in breast cancer risk, and that age may affect these relationships.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat van den Brandt PA, Spiegelman D, Yaun S-S et al (2000) Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152(6):514–527PubMedCrossRef van den Brandt PA, Spiegelman D, Yaun S-S et al (2000) Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152(6):514–527PubMedCrossRef
2.
Zurück zum Zitat Trentham-Dietz A, Newcomb PA, Storer BE et al (1997) Body size and risk of breast cancer. Am J Epidemiol 145(11):1011–1019PubMed Trentham-Dietz A, Newcomb PA, Storer BE et al (1997) Body size and risk of breast cancer. Am J Epidemiol 145(11):1011–1019PubMed
3.
Zurück zum Zitat Friedenreich CM (2001) Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 10(1):15–32PubMedCrossRef Friedenreich CM (2001) Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 10(1):15–32PubMedCrossRef
4.
Zurück zum Zitat Swanson CA, Coates RJ, Schoenberg JB et al (1996) Body size and breast cancer risk among women under age 45 years. Am J Epidemiol 143(7):698–706PubMed Swanson CA, Coates RJ, Schoenberg JB et al (1996) Body size and breast cancer risk among women under age 45 years. Am J Epidemiol 143(7):698–706PubMed
5.
Zurück zum Zitat Tretli S (1989) Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570, 000 women in Norway. Int J Cancer 44(1):23–30PubMedCrossRef Tretli S (1989) Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570, 000 women in Norway. Int J Cancer 44(1):23–30PubMedCrossRef
6.
Zurück zum Zitat Morimoto LM, White E, Chen Z et al (2002) Obesity, body size, and risk of postmenopausal breast cancer: the Women’s Health Initiative (United States). Cancer Causes Control 13(8):741–751PubMedCrossRef Morimoto LM, White E, Chen Z et al (2002) Obesity, body size, and risk of postmenopausal breast cancer: the Women’s Health Initiative (United States). Cancer Causes Control 13(8):741–751PubMedCrossRef
7.
Zurück zum Zitat Carmichael AR, Bates T (2004) Obesity and breast cancer: a review of the literature. Breast 13(2):85–92PubMedCrossRef Carmichael AR, Bates T (2004) Obesity and breast cancer: a review of the literature. Breast 13(2):85–92PubMedCrossRef
8.
Zurück zum Zitat Franceschi S, Favero A, La Vecchia C et al (1996) Body size indices and breast cancer risk before and after menopause. Int J Cancer 67(2):181–186PubMedCrossRef Franceschi S, Favero A, La Vecchia C et al (1996) Body size indices and breast cancer risk before and after menopause. Int J Cancer 67(2):181–186PubMedCrossRef
9.
Zurück zum Zitat Palmer JR, Adams-Campbell LL, Boggs DA, Wise LA, Rosenberg L (2007) A prospective study of body size and breast cancer in black women. Cancer Epidemiol Biomarkers Prev 16(9):1795–1802PubMedCrossRef Palmer JR, Adams-Campbell LL, Boggs DA, Wise LA, Rosenberg L (2007) A prospective study of body size and breast cancer in black women. Cancer Epidemiol Biomarkers Prev 16(9):1795–1802PubMedCrossRef
10.
Zurück zum Zitat Huang Z, Hankinson SE, Colditz GA et al (1997) Dual effects of weight and weight gain on breast cancer risk. JAMA 278(17):1407–1411PubMedCrossRef Huang Z, Hankinson SE, Colditz GA et al (1997) Dual effects of weight and weight gain on breast cancer risk. JAMA 278(17):1407–1411PubMedCrossRef
11.
Zurück zum Zitat Borugian MJ, Sheps SB, Kim-Sing C et al (2003) Waist-to-hip ratio and breast cancer mortality. Am J Epidemiol 158(10):963–968PubMedCrossRef Borugian MJ, Sheps SB, Kim-Sing C et al (2003) Waist-to-hip ratio and breast cancer mortality. Am J Epidemiol 158(10):963–968PubMedCrossRef
12.
Zurück zum Zitat Hall IJ, Newman B, Millikan RC, Moorman PG (2000) Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study. Am J Epidemiol 151(8):754–764PubMed Hall IJ, Newman B, Millikan RC, Moorman PG (2000) Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study. Am J Epidemiol 151(8):754–764PubMed
13.
Zurück zum Zitat Le Marchand L, Kolonel L, Earle ME, Mi M (1988) Body size at different periods of life and breast cancer risk. Am J Epidemiol 128(1):137–152PubMed Le Marchand L, Kolonel L, Earle ME, Mi M (1988) Body size at different periods of life and breast cancer risk. Am J Epidemiol 128(1):137–152PubMed
14.
Zurück zum Zitat Nemesure B, Wu SY, Hambleton IR, Leske MC, Hennis AJ (2008) Risk factors for breast cancer in a black population—The Barbados National Cancer Study. Int J Cancer, Oct 9 [Epub ahead of print] Nemesure B, Wu SY, Hambleton IR, Leske MC, Hennis AJ (2008) Risk factors for breast cancer in a black population—The Barbados National Cancer Study. Int J Cancer, Oct 9 [Epub ahead of print]
15.
Zurück zum Zitat SAS System for Windows [computer program] (2003) Version 9.1. SAS Institute, Inc, Cary SAS System for Windows [computer program] (2003) Version 9.1. SAS Institute, Inc, Cary
16.
Zurück zum Zitat Zhang Y, Rosenberg L, Colton T et al (1996) Adult height and risk of breast cancer among white women in a case-control study. Am J Epidemiol 143(11):1123–1128PubMed Zhang Y, Rosenberg L, Colton T et al (1996) Adult height and risk of breast cancer among white women in a case-control study. Am J Epidemiol 143(11):1123–1128PubMed
17.
Zurück zum Zitat Adebamowo CA, Ogundiran TO, Adenipekun AA et al (2003) Obesity and height in urban Nigerian women with breast cancer. Ann Epidemiol 13:455–461PubMedCrossRef Adebamowo CA, Ogundiran TO, Adenipekun AA et al (2003) Obesity and height in urban Nigerian women with breast cancer. Ann Epidemiol 13:455–461PubMedCrossRef
18.
Zurück zum Zitat Palmer JR, Rao RS, Adams-Campbell LL, Rosenberg L (2001) Height and breast cancer risk: results from the Black Women’s Health Study (United States). Cancer Causes Control 12(4):343–348PubMedCrossRef Palmer JR, Rao RS, Adams-Campbell LL, Rosenberg L (2001) Height and breast cancer risk: results from the Black Women’s Health Study (United States). Cancer Causes Control 12(4):343–348PubMedCrossRef
19.
Zurück zum Zitat Gunnell D (2000) Height, insulin-like growth factors and cancer risk. Growth Horm IGF Res 10(Supp1 A):S39–S40PubMedCrossRef Gunnell D (2000) Height, insulin-like growth factors and cancer risk. Growth Horm IGF Res 10(Supp1 A):S39–S40PubMedCrossRef
20.
Zurück zum Zitat Ruder EH, Dorgan JF, Kranz S, Kris-Etherton PM, Hartman TJ (2008) Examining breast cancer growth and lifestyle risk factors: early life, childhood, and adolescence. Clin Breast Cancer 8(4):334–342PubMedCrossRef Ruder EH, Dorgan JF, Kranz S, Kris-Etherton PM, Hartman TJ (2008) Examining breast cancer growth and lifestyle risk factors: early life, childhood, and adolescence. Clin Breast Cancer 8(4):334–342PubMedCrossRef
21.
Zurück zum Zitat Opdahl S, Nilsen TI, Romundstad PR, Vanky E, Carlsen SM, Vatten LJ (2008) Association of size at birth with adolescent hormone levels, body size and age at menarche: relevance for breast cancer risk. Br J Cancer 99(1):201–206PubMedCrossRef Opdahl S, Nilsen TI, Romundstad PR, Vanky E, Carlsen SM, Vatten LJ (2008) Association of size at birth with adolescent hormone levels, body size and age at menarche: relevance for breast cancer risk. Br J Cancer 99(1):201–206PubMedCrossRef
22.
Zurück zum Zitat Li CI, Littman AJ, White E (2007) Relationship between age maximum height is attained, age at menarche, and age at first full-term birth and breast cancer risk. Cancer Epidemiol Biomarkers Prev 16(10):2144–2149PubMedCrossRef Li CI, Littman AJ, White E (2007) Relationship between age maximum height is attained, age at menarche, and age at first full-term birth and breast cancer risk. Cancer Epidemiol Biomarkers Prev 16(10):2144–2149PubMedCrossRef
23.
Zurück zum Zitat Surveillance, Epidemiology, and End Results (SEER) (2007) Program (www.seer.cancer.gov) National Cancer Institute, DCCPS, Surveillance Research Program Surveillance, Epidemiology, and End Results (SEER) (2007) Program (www.​seer.​cancer.​gov) National Cancer Institute, DCCPS, Surveillance Research Program
24.
Zurück zum Zitat Mayberry RM (1994) Age-specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54. Ann Epidemiol 4(3):205–213PubMedCrossRef Mayberry RM (1994) Age-specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54. Ann Epidemiol 4(3):205–213PubMedCrossRef
25.
Zurück zum Zitat Zhu K, Caulfield J, Hunter S, Roland CL, Payne-Wilks K, Texter L (2005) Body mass index and breast cancer risk in African American women. Ann Epidemiol 15(2):123–128PubMedCrossRef Zhu K, Caulfield J, Hunter S, Roland CL, Payne-Wilks K, Texter L (2005) Body mass index and breast cancer risk in African American women. Ann Epidemiol 15(2):123–128PubMedCrossRef
26.
Zurück zum Zitat Adebamowo CA, Adekunle OO (1999) Case-controlled study of the epidemiological risk factors for breast cancer in Nigeria. Br J Surg 86(5):665–668PubMedCrossRef Adebamowo CA, Adekunle OO (1999) Case-controlled study of the epidemiological risk factors for breast cancer in Nigeria. Br J Surg 86(5):665–668PubMedCrossRef
27.
Zurück zum Zitat Huang Z, Willett WC, Colditz GA et al (1999) Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses’ Health Study. Am J Epidemiol 150(12):1316–1324PubMed Huang Z, Willett WC, Colditz GA et al (1999) Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses’ Health Study. Am J Epidemiol 150(12):1316–1324PubMed
28.
Zurück zum Zitat Key TJ, Pike MC (1988) The role of oestrogens and progesterone in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24(1):29–43PubMedCrossRef Key TJ, Pike MC (1988) The role of oestrogens and progesterone in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24(1):29–43PubMedCrossRef
29.
Zurück zum Zitat Bulbrook RD, Moore JW, Clark GM, Wang DY, Tong D, Hayward JL (1978) Plasma oestradiol and progesterone levels in women with varying degrees of risk of breast cancer. Eur J Cancer 14(12):1369–1375PubMed Bulbrook RD, Moore JW, Clark GM, Wang DY, Tong D, Hayward JL (1978) Plasma oestradiol and progesterone levels in women with varying degrees of risk of breast cancer. Eur J Cancer 14(12):1369–1375PubMed
30.
Zurück zum Zitat Cowan LD, Gordis L, Tonascia JA, Jones GS (1981) Breast cancer incidence in women with a history of progesterone deficiency. Am J Epidemiol 114(2):209–217PubMed Cowan LD, Gordis L, Tonascia JA, Jones GS (1981) Breast cancer incidence in women with a history of progesterone deficiency. Am J Epidemiol 114(2):209–217PubMed
31.
Zurück zum Zitat Adebamowo CA, Ogundiran TO, Adenipekun AA et al (2003) Waist-hip ratio and breast cancer risk in urbanized Nigerian women. Breast Cancer Res 5(2):R18–R24PubMedCrossRef Adebamowo CA, Ogundiran TO, Adenipekun AA et al (2003) Waist-hip ratio and breast cancer risk in urbanized Nigerian women. Breast Cancer Res 5(2):R18–R24PubMedCrossRef
32.
Zurück zum Zitat Kushi LH, Kaye SA, Folsom AR, Soler JT, Prineas RJ (1988) Accuracy and reliability of self-measurement of body girths. Am J Epidemiol 128(4):740–748PubMed Kushi LH, Kaye SA, Folsom AR, Soler JT, Prineas RJ (1988) Accuracy and reliability of self-measurement of body girths. Am J Epidemiol 128(4):740–748PubMed
33.
Zurück zum Zitat Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC (1990) Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1(6):466–473PubMedCrossRef Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC (1990) Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1(6):466–473PubMedCrossRef
34.
Zurück zum Zitat Stewart AL (1982) The reliability and validity of self-reported weight and height. J Chronic Dis 35(4):295–309PubMedCrossRef Stewart AL (1982) The reliability and validity of self-reported weight and height. J Chronic Dis 35(4):295–309PubMedCrossRef
35.
Zurück zum Zitat Munoz KA, Ballard-Barbash R, Graubard B, Swanson CA, Schairer C, Kahle LL (1996) Recall of body weight and body size estimation in women enrolled in the breast cancer detection and demonstration project (BCDDP). Int J Obes Relat Metab Disord 20(9):854–859PubMed Munoz KA, Ballard-Barbash R, Graubard B, Swanson CA, Schairer C, Kahle LL (1996) Recall of body weight and body size estimation in women enrolled in the breast cancer detection and demonstration project (BCDDP). Int J Obes Relat Metab Disord 20(9):854–859PubMed
36.
Zurück zum Zitat Perry GS, Byers TE, Mokdad AH, Serdula MK, Williamson DF (1995) The validity of self-reports of past body weights by U.S. adults. Epidemiology 6(1):61–66PubMedCrossRef Perry GS, Byers TE, Mokdad AH, Serdula MK, Williamson DF (1995) The validity of self-reports of past body weights by U.S. adults. Epidemiology 6(1):61–66PubMedCrossRef
37.
Zurück zum Zitat IARC (2001) GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. Version 1.0. IARC CancerBase No. 5. IARC Press, Lyon IARC (2001) GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. Version 1.0. IARC CancerBase No. 5. IARC Press, Lyon
Metadaten
Titel
Body size and breast cancer in a black population—The Barbados National Cancer Study
verfasst von
Barbara Nemesure
Suh-Yuh Wu
Anselm Hennis
M. Cristina Leske
Barbados National Cancer Study Group
Publikationsdatum
01.04.2009
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 3/2009
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-008-9253-3

Weitere Artikel der Ausgabe 3/2009

Cancer Causes & Control 3/2009 Zur Ausgabe

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.